NEW YORK (GenomeWeb News) — Compugen today reported zero revenues for the third quarter as net losses declined 30 percent.
 
Receipts for the three months ended Sept. 30, 2005, were $95,000, Compugen said.
 
R&D spending for the quarter declined 26 percent to $1.7 million from $2.3 million in 2005.
 
Compugen said net losses in the quarter declined 30 percent to $2.5 million  percent from $3.6 million year over year.  
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.